Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anderson-Fabry disease].

Petar Kes1, Nikolina Basić-Jukić, Bruna Brunetta

  • 1Zavod za dijalizu, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska. kespetar@net.hr

Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
|June 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026
Same author

Anti-Obesity Medications in Adults with Congenital Heart Disease: A Comprehensive Review and Expert Clinical Recommendations.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Long-Term Outcome of Kidney Transplant Patients from Rural Farming Areas with Balkan Nephropathy-A Single-Centre Report.

Journal of clinical medicine·2026
Same author

Post-Transplant Sepsis After Liver Transplantation: Clinical Characteristics and Therapeutic Challenges.

Journal of clinical medicine·2026
Same author

Uremic Pruritus in Hemodialysis: Mechanisms, Burden, and Emerging Therapies.

Journal of clinical medicine·2026
Same author

Exploring Perspectives on Kidney Donation: Medical and Non-Medical Students in Croatia.

Journal of clinical medicine·2026

Anderson-Fabry disease is a rare X-linked genetic disorder caused by a deficiency in alpha-galactosidase A. This leads to progressive Gb3 accumulation, impacting multiple organs and potentially causing severe health complications.

Area of Science:

  • Genetics and rare diseases
  • Lysosomal storage disorders
  • Enzyme deficiencies

Context:

  • Anderson-Fabry disease is a rare, inherited X-linked lysosomal storage disorder.
  • It results from a deficiency of the enzyme alpha-galactosidase A.
  • This deficiency causes the abnormal accumulation of globotriaosylceramide (Gb3) in lysosomes.

Purpose:

  • To provide an overview of Anderson-Fabry disease.
  • To highlight its genetic basis, pathophysiology, and clinical manifestations.
  • To discuss current treatment approaches, including enzyme replacement therapy.

Summary:

  • Anderson-Fabry disease is characterized by progressive Gb3 accumulation due to alpha-galactosidase A deficiency, affecting multiple organ systems.
  • Symptoms include neuropathic pain, angiokeratomas, and ophthalmological abnormalities, with potential progression to cardiac, renal, and cerebrovascular complications.

Related Experiment Videos

  • Enzyme replacement therapies, agalsidase alpha and agalsidase beta, were approved in 2001.

    • Impact:

    • Increased understanding of Anderson-Fabry disease's complex pathophysiology.
    • Highlights the significance of enzyme replacement therapy for rare genetic disorders.
    • Provides a foundation for further research into treatment and management strategies.